Down 47% From Its All-Time High, This Is the Most Undervalued Cryptocurrency to Buy Right Now

Ethereum trades near $2,600, 47% below its August all-time high of $4,954, amid negative momentum and uncertainty after the Clarity Act failed to advance in a September Senate vote. The bullish case rests on Ethereum's 56% share of crypto total value locked and leadership in stablecoins and real-world asset tokenization, alongside continued ETF inflows and treasury-company purchases. Risks include intensifying Layer-1 competition from Solana, Cardano, Avalanche, Aptos, Sui, and Circle's Arc, while Ethereum has lagged AI-focused blockchain rivals in investor attention. Bullish price targets near $10,000 imply roughly 4x upside from current levels, although these targets are speculative.

Analysis

The investable question is not whether Ethereum retains protocol leadership, but whether that leadership converts into ETH value accrual. Stablecoin and tokenized-asset activity can expand substantially while fees migrate to L2s, sequencers, or issuer-controlled chains; that is the key reason network-use narratives have repeatedly failed to support ETH on a one-for-one basis. Near term, regulatory uncertainty is more likely to suppress broad altcoin beta than impair stablecoin transaction growth, creating a distinction between protocol usage and token performance.

CRCL is the clearest listed second-order beneficiary if regulated stablecoin adoption broadens, but a proprietary Arc ecosystem would make it a partial substitute for Ethereum rather than a pure read-through. The critical diligence item is whether Arc is permissioned, who captures sequencing/fee economics, and whether USDC liquidity remains interoperable across Ethereum L2s; closed-loop adoption would weaken ETH's share of the highest-value settlement flows. Conversely, institutional tokenization providers generally prioritize liquidity, compliance tooling, and distribution over raw chain throughput, which remains a structural advantage for Ethereum-linked rails over newer L1s.

Consensus appears too focused on the prior peak as valuation support. ETH needs a catalyst that changes marginal capital flows—sustained ETF net creations, a credible upgrade-driven reduction in costs without further fee leakage, or legislative clarity—not merely a rebound in crypto risk appetite. Over the next 1-3 months, ETH should trade as high-beta liquidity exposure; over 6-18 months, its relative performance versus SOL will be determined by net fee capture and stablecoin/RWA settlement share, not TVL alone.

A failed thesis would be persistent ETH/SOL underperformance alongside rising Ethereum ecosystem activity, signaling that value is accruing outside ETH, or meaningful migration of USDC settlement and tokenized-asset issuance to Arc. On the upside, sustained ETF inflows plus improving burn/fee metrics would justify re-rating; absent those data, large upside price targets are narrative rather than an earnings-like valuation case.

Key Decisions for Investors

• No directional ETH position solely on the drawdown. Establish a monitoring trigger for weekly spot-ETH ETF net flows, Ethereum fee/burn trends, and ETH/SOL relative strength; consider a tactical ETH long only after ETF flows turn persistently positive and ETH/SOL breaks a 3-month downtrend.
• Use a 1-3 month relative-value expression rather than outright altcoin beta: long ETH / short SOL in matched volatility only if institutional tokenization or stablecoin issuance data demonstrably favor Ethereum-linked settlement. Exit if ETH/SOL makes a new relative low after the next major Ethereum upgrade milestone.
• Treat CRCL as a separate stablecoin-distribution exposure, not an Ethereum proxy. Avoid adding on Arc launch headlines; wait for disclosed economics, ecosystem incentives, and evidence of USDC supply growth that exceeds the cost of incentives. A closed Arc liquidity pool is bearish for ETH's incremental settlement share but not necessarily for CRCL revenue.
• For a 6-18 month structural allocation, prefer limited-risk ETH call spreads over spot only after regulatory timing becomes clearer; target upside through a prior-cycle resistance zone while capping premium at risk. Do not underwrite a return to prior highs without confirmation that protocol fees and institutional flows are rising together.